Neurology
Main Filters
Neurology
| Cardinal Health | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 26-5342I | 0 | - | ||
| PN11CLS25 | 0 | - | ||
| PN11NEXX4 | 0 | - | ||
| PN23SNB17 | 0 | - | ||
| PN30LMP17 | 0 | - | ||
| PN33CFAD8 | 0 | - | ||
| PN33LMAD5 | 0 | - | ||
| PN40CSJU2 | 0 | - | ||
| PN76CRH21 | 0 | - | ||
| PNCGACA25 | 0 | - | ||
| PNCGLLBM6 | 0 | - | ||
| PNDHNMPCC | 0 | - | ||
| PNHDFSV10 | 0 | - | ||
| PNV2SFCP6 | 0 | - | ||
| PNVMSUA215 | 0 | - | ||
| PNVMTR219 | 0 | - | ||
| PNVPLM015 | 0 | - | ||
| SAN21NAPM9 | 0 | - | ||
| SNE11IRLV2 | 0 | - | ||
| SNE11LMJ21 | 0 | - | ||
| SNE11NRU17 | 0 | - | ||
| SNE11SPJ10 | 0 | - | ||
| SNE12ACWC4 | 0 | - | ||
| SNE12CF310 | 0 | - | ||
| SNE12CF34D | 0 | - | ||
| SNE13NLGL1 | 0 | - | ||
| SNE23CRVDY | 0 | - | ||
| SNE23HSUC1 | 0 | - | ||
| SNE26CRHR6 | 0 | - | ||
| SNE32CRSP9 | 0 | - | ||
| SNE33CR517 | 0 | - | ||
| SNE35NE311 | 0 | - | ||
| SNE43LMBML | 0 | - | ||
| SNE43LNOG4 | 0 | - | ||
| SNE43NPM13 | 0 | - | ||
| SNE44OMMDH | 0 | - | ||
| SNE53LPPV4 | 0 | - | ||
| SNE73LMHP6 | 0 | - | ||
| SNECGACRO5 | 0 | - | ||
| SNECGCRRI9 | 0 | - | ||
| SNECGNSEBF | 0 | - | ||
| SNEDHCRCF6 | 0 | - | ||
| SNEDKCPRP4 | 0 | - | ||
| SNEOCNEBYA | 0 | - | ||
| SNEOCNUBYA | 0 | - | ||
| SNEOCSPBK3 | 0 | - | ||
| PEAR THERAPEUTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1 | 0 | - | ||
| 1 | 0 | - | ||
| 1 | 0 | - | ||
| 1 | 0 | - | ||
124,195 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
reSET-O® Non-Monetary CM
PEAR THERAPEUTICS, INC.
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives to patients based on the Contingency management system.
0
-
reSET-O®
PEAR THERAPEUTICS, INC.
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.
0
-
reSET® Non-Monetary CM
PEAR THERAPEUTICS, INC.
reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program This configuration of reSET is intended to provide virtual incentives to patients based on the Contingency management system.
0
-
reSET®
PEAR THERAPEUTICS, INC.
reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program. This configuration of reSET is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.